Page 87 - GALENIKA MEDICAL JOURNAL
P. 87

Literatura                                          15.  Olney NT, Spina S, Miller BL. Frontotemporal Dementia. Neurologic
                                                                  Clinics. 2017; 35(2):339-74.
            1.  Widiger TA, Frances AJ, Pincus HAE, Ross RE. DSM-IV sourcebook, Vol. 3.   16.  Finger EC. Frontotemporal Dementias. Continuum: Lifelong Learning in
                                                                  Neurology. 2016; 22(2):464-89.
               American Psychiatric Publishing, Inc. 1997.
                                                                17.  Tabrizi SJ, Ghosh R, Leavitt BR. Huntingtin lowering strategies for
            2.  Pujol DJ, Azpiazu APD. Dementia DSM-IV/ICD-10 or neurocognitive   disease modification in Huntington’s disease. Neuron. 2019; 101(5):801-
               disorder DSM-5? The European Journal of Psychiatry. 2015;29(1):45-50.  19.
            3.  Provias J, Jeynes B. Brain pathology brain pathology. Brain Pathology.   18.  Hong EP, MacDonald ME, Wheeler VC, Jones L, Holmans P, Orth M, et
               2014; 24(1):39-103.                                al. Huntington’s disease pathogenesis: Two sequential components.
            4.  Nestor PJ, Altomare D, Festari C, Drzezga A, Rivolta J, Walker Z et al.   Journal of Huntington's Disease. 2021;10(1):35-51.
               Clinical utility of FDG-PET for the differential diagnosis among the   19.  Barnat M, Capizzi M, Aparicio E, Boluda S, Wennagel D, Kacher R, et al.
               main forms of dementia. European journal of nuclear medicine and   Huntington’s disease alters human neurodevelopment. Science. 2020;
               molecular imaging. 2018; 45(9): 1509-25.           369(6505):787-93.
            5.  Wallukat G, Prüss H, Müller J, Schimke I. Functional autoantibodies   20.  Vinciguerra L, Lanza G, Puglisi V, Fisicaro F, Pennisi M, Bella R, et al.
               in patients with different forms of dementia. PLoS One. 2018; 13(3):   Update on the neurobiology of vascular cognitive impairment: from lab
               e0192778.                                          to clinic. International Journal of Molecular Sciences. 2020; 21(8):2977.
            6.  Matej R, Tesar A, Rusina R. Alzheimer's disease and other   21.  Borges MK, Canevelli M, Cesari M, Aprahamian I. Frailty as a predictor
               neurodegenerative dementias in comorbidity: a clinical and   of cognitive disorders: a systematic review and meta-analysis. Frontiers
               neuropathological overview. Clinical biochemistry. 2019; 73:26-31.  in medicine. 2019; 6:26.
            7.  Desmarais P, Lanctôt KL, Masellis M, Black SE, Herrmann N. Social   22.  Sipilä PN, Heikkilä  N, Lindbohm JV, Hakulinen C, Vahtera J, Elovainio M,
               inappropriateness in neurodegenerative disorders. International   et al. Hospital-treated infectious diseases and the risk of dementia: a
               psychogeriatrics, 2018. 30(2); 197-207.            large, multicohort, observational study with a replication cohort. The
            8.  Sancesario GM, Bernardini S. Diagnosis of neurodegenerative   Lancet Infectious Diseases. 2021;21(11):1557-67.
               dementia: where do we stand, now?. Annals of translational medicine.   23.  Lam JO, Hou CE, Hojilla JC, Anderson AN, Gilsanz P, Alexeeff SE, et al.
               2018;6(17).                                        Comparison of dementia risk after age 50 between individuals with and
            9.  Cations M, Draper B, Low LF, Radford K, Trollor J, Brodaty H, et al.   without HIV infection. AIDS. 2021;35(5):821-8.
               Non-genetic risk factors for degenerative and vascular young onset   24.  Lazarevic M. The relationship of the use of drugs that disturb the
               dementia: results from the INSPIRED and KGOW studies. Journal of   metabolism of vitamin B12  and mild cognitive disorders in patients in
               Alzheimer's Disease. 2018; 62(4):1747-58.          primary health care. Doctoral dissertation. University of Kragujevac.
            10.  Wang CSM, Wu JY, Hsu WT, Chien PF, Chen PL, Huang YC, et al. Using   2023.
               Self-Administered Game-Based Cognitive Assessment to Screen for
               Degenerative Dementia: A Pilot Study. Journal of Alzheimer's Disease,
               (Preprint). 2022; 1-14.                            Konflikt interesa: Nema
            11.  Koychev I, Hofer M, Friedman N. Correlation of Alzheimer disease   Primljeno: 12. 11. 2024.
               neuropathologic staging with amyloid and tau scintigraphic imaging
               biomarkers. Journal of Nuclear Medicine. 2020; 61(10):1413-8.  Prihvaćeno: 29. 11. 2024.
                                                                  Onlajn: 31. 12. 2024.
            12.  Hippius H, Neundörfer G. The discovery of Alzheimer's disease.
               Dialogues in clinical neuroscience. 2022.
            13.  Zvěřová M. Clinical aspects of Alzheimer's disease. Clinical biochemistry.
               2019; 72:3-6.
            14.  Mandić-Stojmenović G, Kostić V, Stefanova E. The clinical spectrum of
               frontotemporal dementia. Medicinski podmladak. 2018;69(2):9-15.








































            REVIJALNI RADOVI                                                 Galenika Medical Journal, 2024; 3(12):81-85.  85
   82   83   84   85   86   87   88   89   90   91   92